Home Newsfeeds RBC Capital Downgrades Adient to Sector Perform, Announces $36 Price Target

RBC Capital Downgrades Adient to Sector Perform, Announces $36 Price Target

RBC Capital analyst Joseph Spak downgrades Adient (NYSE:ADNT) from Outperform to Sector Perform and announces $36 price target.

byBenzinga Newsdesk

November 7, 2022

1 minute read

RBC Capital analyst Joseph Spak downgrades Adient (NYSE:ADNT) from Outperform to Sector Perform and announces $36 price target.

MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib

By Vandana Singh

April 29, 12:36 PM

MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly to acute myeloid leukemia. FDA alerted. Novartis acquisition proceeds despite setbacks.

MOR

Alpine 4 Holdings, Inc. Subsidiary, Quality Circuit Assembly, Inc. Adds $1.8M In New EV And ESS Assembly Work For Q3 And Q4 2023

By Happy Mohamed

August 15, 12:35 PM

Alpine 4 Holdings, Inc. (NASDAQ:ALPP), a leading operator and owner of small market businesses, announced today that its subsidiary, Quality Circuit Assembly, Inc. (QCA) has secured $1.8 million in new Electric

ALPP